Estudo randomizado | Eficácia e segurança de dose ultra-alta de metilcobalamina na esclerose lateral amiotrófica em estágio inicial.

Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial – JAMA Neurology (link para o resumo – $ para o texto completo)

Comentário no Twitter

A phase 3 clinical trial found ultra-high dose methylcobalamin slowed functional decline in patients with early-stage amyotrophic lateral sclerosis. https://t.co/r5KP38JkUc

— JAMA Neurology (@JAMANeuro) May 9, 2022